Home Newsletters Human Immunology News MET Amplification Attenuates Lung Tumor Response to Immunotherapy by Inhibiting STING

MET Amplification Attenuates Lung Tumor Response to Immunotherapy by Inhibiting STING

0
Scientists examined 81 lung cancer patients under immune checkpoint blockade (ICB) treatment and found that patients with MET amplification were resistant to ICB and had a poor progress-free survival.
[Cancer Discovery]
6445218 {6445218:DDR2256N} apa 50 1 163190 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3A%22zotpress-964c55aec30d3d39c8c57d30036d1d96%22%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22DDR2256N%22%2C%22library%22%3A%7B%22id%22%3A6445218%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Zhang%20et%20al.%22%2C%22parsedDate%22%3A%222021-01-01%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3EZhang%2C%20Y.%2C%20Yang%2C%20Q.%2C%20Zeng%2C%20X.%2C%20Wang%2C%20M.%2C%20Dong%2C%20S.%2C%20Yang%2C%20B.%2C%20Tu%2C%20X.%2C%20Wei%2C%20T.%2C%20Xie%2C%20W.%2C%20Zhang%2C%20C.%2C%20Guo%2C%20Q.%2C%20Kloeber%2C%20J.%20A.%2C%20Cao%2C%20Y.%2C%20Guo%2C%20G.%2C%20Zhou%2C%20Q.%2C%20Zhao%2C%20F.%2C%20Huang%2C%20J.%2C%20Liu%2C%20L.%2C%20Zhang%2C%20K.%2C%20%26%23x2026%3B%20Lou%2C%20Z.%20%282021%29.%20MET%20amplification%20attenuates%20lung%20tumor%20response%20to%20immunotherapy%20by%20inhibiting%20STING.%20%3Ci%3ECancer%20Discovery%3C%5C%2Fi%3E.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1158%5C%2F2159-8290.CD-20-1500%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1158%5C%2F2159-8290.CD-20-1500%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.stemcellsciencenews.com%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D6445218%26amp%3Bitem_key%3DDDR2256N%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22MET%20amplification%20attenuates%20lung%20tumor%20response%20to%20immunotherapy%20by%20inhibiting%20STING%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yong%22%2C%22lastName%22%3A%22Zhang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Qifan%22%2C%22lastName%22%3A%22Yang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Xiangyu%22%2C%22lastName%22%3A%22Zeng%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Manxiang%22%2C%22lastName%22%3A%22Wang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Shuang%22%2C%22lastName%22%3A%22Dong%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Bin%22%2C%22lastName%22%3A%22Yang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Xinyi%22%2C%22lastName%22%3A%22Tu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ting%22%2C%22lastName%22%3A%22Wei%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wenzhuan%22%2C%22lastName%22%3A%22Xie%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Chao%22%2C%22lastName%22%3A%22Zhang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Qiang%22%2C%22lastName%22%3A%22Guo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jake%20A.%22%2C%22lastName%22%3A%22Kloeber%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yueyu%22%2C%22lastName%22%3A%22Cao%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Guijie%22%2C%22lastName%22%3A%22Guo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Qin%22%2C%22lastName%22%3A%22Zhou%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Fei%22%2C%22lastName%22%3A%22Zhao%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jinzhou%22%2C%22lastName%22%3A%22Huang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Li%22%2C%22lastName%22%3A%22Liu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kai%22%2C%22lastName%22%3A%22Zhang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mingwei%22%2C%22lastName%22%3A%22Wang%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ping%22%2C%22lastName%22%3A%22Yin%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kuntian%22%2C%22lastName%22%3A%22Luo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Min%22%2C%22lastName%22%3A%22Deng%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Wootae%22%2C%22lastName%22%3A%22Kim%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jing%22%2C%22lastName%22%3A%22Hou%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yu%22%2C%22lastName%22%3A%22Shi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Qian%22%2C%22lastName%22%3A%22Zhu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lifeng%22%2C%22lastName%22%3A%22Chen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sheng%22%2C%22lastName%22%3A%22Hu%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Junqiu%22%2C%22lastName%22%3A%22Yue%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Guoliang%22%2C%22lastName%22%3A%22Pi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Zhenkun%22%2C%22lastName%22%3A%22Lou%22%7D%5D%2C%22abstractNote%22%3A%22Immune%20checkpoint%20blockade%20%28ICB%29%20has%20revolutionized%20cancer%20therapy.%20However%2C%20the%20response%20of%20patients%20to%20ICB%20is%20difficult%20to%20predict.%20Here%2C%20we%20examined%2081%20lung%20cancer%20patients%20under%20ICB%20treatment%20and%20found%20that%20patients%20with%20MET%20amplification%20were%20resistant%20to%20ICB%20and%20had%20a%20poor%20progress-free%20survival.%20Tumors%20with%20MET%20amplifications%20had%20significantly%20decreased%20STING%20levels%20and%20antitumor%20T%20cell%20infiltration.%20Furthermore%2C%20we%20performed%20deep%20single-cell%20RNA%20sequencing%20on%20more%20than%2020000%20single%20immune%20cells%20and%20identified%20an%20immunosuppressive%20signature%20with%20increased%20subsets%20of%20XIST-%20and%20CD96-positive%20exhausted%20NK%20cells%20and%20decreased%20CD8%2B%20T%20cell%20and%20NK%20cell%20populations%20in%20patients%20with%20MET-amplification.%20Mechanistically%2C%20we%20found%20that%20oncogenic%20MET%20signaling%20induces%20phosphorylation%20of%20UPF1%20and%20downregulates%20tumor%20cell%20STING%20expression%20via%20modulation%20of%20the%203%5Cu2032-UTR%20length%20of%20STING%20by%20UPF1.%20Decreased%20efficiency%20of%20ICB%20by%20MET%20amplification%20can%20be%20overcome%20by%20inhibiting%20MET.%22%2C%22date%22%3A%222021%5C%2F01%5C%2F01%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1158%5C%2F2159-8290.CD-20-1500%22%2C%22ISSN%22%3A%222159-8274%2C%202159-8290%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fcancerdiscovery.aacrjournals.org%5C%2Fcontent%5C%2Fearly%5C%2F2021%5C%2F06%5C%2F04%5C%2F2159-8290.CD-20-1500%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222021-06-08T18%3A11%3A36Z%22%7D%7D%5D%7D
Zhang, Y., Yang, Q., Zeng, X., Wang, M., Dong, S., Yang, B., Tu, X., Wei, T., Xie, W., Zhang, C., Guo, Q., Kloeber, J. A., Cao, Y., Guo, G., Zhou, Q., Zhao, F., Huang, J., Liu, L., Zhang, K., … Lou, Z. (2021). MET amplification attenuates lung tumor response to immunotherapy by inhibiting STING. Cancer Discovery. https://doi.org/10.1158/2159-8290.CD-20-1500 Cite
Abstract
Exit mobile version